URABRELIMAB
UNII W6284A5K8N

Substance Identification & Data

This profile provides standardized clinical and technical data for Urabrelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W6284A5K8N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2249722-58-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
W6284A5K8N
CAS Registry Number
2249722-58-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
URABRELIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11236
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Urabrelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

URABRELIMAB

Common Names & Synonyms

URABRELIMAB [INN]
URABRELIMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN IGG4, ANTI-(HUMAN CD47) (HUMAN MONOCLONAL SRF231 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL SRF231 .KAPPA.-CHAIN, DIMER

Technical Codes

SRF231
SRF-231